研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

炎症诱导的表观遗传印记调节肠道干细胞。

Inflammation-induced epigenetic imprinting regulates intestinal stem cells.

发表日期:2024 Oct 03
作者: Dongchang Zhao, Visweswaran Ravikumar, Tyler J Leach, Daniel Kraushaar, Emma Lauder, Lu Li, Yaping Sun, Katherine Oravecz-Wilson, Evan T Keller, Fengju Chen, Laure Maneix, Robert R Jenq, Robert Britton, Katherine Y King, Ana E Santibanez, Chad J Creighton, Arvind Rao, Pavan Reddy
来源: Cell Stem Cell

摘要:

目前尚不清楚肠道干细胞(ISC)是否以及如何适应炎症暴露,以及这种适应是否会留下影响其随后再生的疤痕。我们在明确的临床相关急性胃肠道移植物抗宿主病 (GI GVHD) 模型中研究了炎症对 Lgr5 ISC 的影响。利用单细胞转录组学以及类器官、代谢、表观基因组和体内模型,我们发现 Lgr5 ISC 经历代谢变化,导致琥珀酸的积累,从而重新编程其表观基因组。这些变化降低了 ISC 在连续类器官培养物中以及在连续移植后的体内分化和再生的能力。此外,尽管最初的炎症暴露得到了解决,但 ISC 的体内再生能力却下降,这表明炎症遭遇引起的适应不良影响仍然存在。因此,炎症以一种持续存在的方式在 ISC 的表观基因组上留下印记,并影响它们适应未来压力或挑战的敏感性。版权所有 © 2024 作者。由爱思唯尔公司出版。保留所有权利。
It remains unknown whether and how intestinal stem cells (ISCs) adapt to inflammatory exposure and whether the adaptation leaves scars that will affect their subsequent regeneration. We investigated the consequences of inflammation on Lgr5+ ISCs in well-defined clinically relevant models of acute gastrointestinal graft-versus-host disease (GI GVHD). Utilizing single-cell transcriptomics, as well as organoid, metabolic, epigenomic, and in vivo models, we found that Lgr5+ ISCs undergo metabolic changes that lead to the accumulation of succinate, which reprograms their epigenome. These changes reduced the ability of ISCs to differentiate and regenerate ex vivo in serial organoid cultures and also in vivo following serial transplantation. Furthermore, ISCs demonstrated a reduced capacity for in vivo regeneration despite resolution of the initial inflammatory exposure, demonstrating the persistence of the maladaptive impact induced by the inflammatory encounter. Thus, inflammation imprints the epigenome of ISCs in a manner that persists and affects their sensitivity to adapt to future stress or challenges.Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.